ONTOLOGY REPORT - ANNOTATIONS
| Term: | manganese atom |
|
| Accession: | CHEBI:18291
|
browse the term
|
| Definition: | A manganese group element atom that has formula Mn. |
| Synonyms: | related_synonym: | 25Mn; InChI=1S/Mn; InChIKey=PWHULOQIROXLJO-UHFFFAOYSA-N; Mangan; Manganese; Mn; manganeso; manganum |
| | alt_id: | CHEBI:13382; CHEBI:25153; CHEBI:6681 |
| | xref_casrn: | 7439-96-5 |
| | xref: | ChemIDplus:7439-96-5 "CAS Registry Number"; KEGG COMPOUND:7439-96-5 "CAS Registry Number"; KEGG COMPOUND:C00034 "KEGG COMPOUND" |
| | xref_mesh: | MESH:D008345 |
| | xref: | WebElements:Mn "WebElements" |
|
|
manganese atom
|
| G |
Abca5 |
ATP-binding cassette, subfamily A (ABC1), member 5 |
|
decreases expression |
ISO |
10 |
99,724,778 |
99,793,593 |
RGD:6480464 |
CTD |
| G |
Abca9 |
ATP-binding cassette, subfamily A (ABC1), member 9 |
|
increases expression |
ISO |
10 |
99,558,803 |
99,619,870 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
multiple interactions |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abi2 |
abl-interactor 2 |
|
increases expression |
ISO |
9 |
59,028,651 |
59,079,887 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
decreases activity |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases activity |
ISO |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases activity |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
multiple interactions |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases activity |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases expression |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
decreases expression |
ISO |
1 |
20,573,215 |
20,704,564 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
|
increases expression |
ISO |
1 |
137,672,485 |
137,675,472 |
RGD:6480464 |
CTD |
| G |
Apol2 |
apolipoprotein L, 2 |
|
increases expression |
ISO |
7 |
115,668,899 |
115,673,029 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases expression |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
multiple interactions |
EXP |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects binding |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects binding |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
decreases expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
|
increases expression |
ISO |
9 |
33,395,974 |
33,539,597 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
increases phosphorylation |
EXP |
7 |
138,971,063 |
139,014,690 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
multiple interactions |
EXP |
7 |
138,971,063 |
139,014,690 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
decreases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp13a2 |
ATPase type 13A2 |
|
affects response to substance |
ISO |
5 |
159,847,016 |
159,866,362 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
increases phosphorylation |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
decreases expression |
ISO |
14 |
42,923,309 |
43,165,666 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
increases expression |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
decreases expression |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Calcoco2 |
calcium binding and coiled-coil domain 2 |
|
increases expression |
ISO |
10 |
84,820,832 |
84,847,065 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Cd48 |
Cd48 molecule |
|
increases expression |
ISO |
13 |
87,684,545 |
87,708,091 |
RGD:6480464 |
CTD |
| G |
Cd8b |
CD8b molecule |
|
increases expression |
ISO |
4 |
104,536,454 |
104,552,683 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
ISO |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
increases expression |
ISO |
7 |
123,900,366 |
124,036,122 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
decreases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
|
decreases expression |
ISO |
7 |
55,823,982 |
55,880,812 |
RGD:6480464 |
CTD |
| G |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
|
increases expression |
ISO |
14 |
14,924,620 |
15,011,984 |
RGD:6480464 |
CTD |
| G |
Col12a1 |
collagen, type XII, alpha 1 |
|
decreases expression |
ISO |
8 |
84,641,358 |
84,756,923 |
RGD:6480464 |
CTD |
| G |
Cpm |
carboxypeptidase M |
|
decreases expression |
ISO |
7 |
56,931,920 |
56,992,248 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
decreases expression |
ISO |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
increases expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
increases expression |
ISO |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
decreases response to substance |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
decreases response to substance |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Dach2 |
dachshund homolog 2 (Drosophila) |
|
increases expression |
ISO |
X |
102,020,017 |
102,585,398 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
multiple interactions |
ISO |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
decreases expression |
ISO |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
|
decreases expression |
ISO |
9 |
9,865,096 |
9,867,833 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
increases expression |
ISO |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dr1 |
down-regulator of transcription 1 |
|
decreases expression |
ISO |
14 |
2,005,938 |
2,017,291 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
increases expression |
ISO |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
decreases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
increases expression |
ISO |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Elf1 |
E74-like factor 1 |
|
decreases expression |
ISO |
15 |
60,793,794 |
60,835,189 |
RGD:6480464 |
CTD |
| G |
Eml2 |
echinoderm microtubule associated protein like 2 |
|
increases expression |
ISO |
1 |
78,539,321 |
78,570,125 |
RGD:6480464 |
CTD |
| G |
Emr1 |
EGF-like module containing, mucin-like, hormone receptor-like 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases glycosylation |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 - like |
|
decreases expression |
ISO |
X |
90,195,080 |
90,212,006 |
RGD:6480464 |
CTD |
| G |
Ereg |
epiregulin |
|
increases expression |
ISO |
14 |
18,521,069 |
18,534,844 |
RGD:6480464 |
CTD |
| G |
Erich1 |
glutamate-rich 1 |
|
increases expression |
ISO |
16 |
80,333,204 |
80,404,945 |
RGD:6480464 |
CTD |
| G |
Exoc6 |
exocyst complex component 6 |
|
decreases expression |
ISO |
1 |
241,964,047 |
242,008,416 |
RGD:6480464 |
CTD |
| G |
Eya4 |
eyes absent homolog 4 (Drosophila) |
|
decreases expression |
ISO |
1 |
22,814,568 |
22,914,973 |
RGD:6480464 |
CTD |
| G |
Fancf |
Fanconi anemia, complementation group F |
|
decreases expression |
ISO |
1 |
101,664,895 |
101,666,720 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
decreases expression |
ISO |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Flcn |
folliculin |
|
increases expression |
ISO |
10 |
46,110,527 |
46,129,613 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxp2 |
forkhead box P2 |
|
increases expression |
ISO |
4 |
40,719,812 |
40,977,517 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
increases expression |
ISO |
8 |
48,379,075 |
48,385,553 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
increases expression |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
increases expression |
ISO |
1 |
205,936,352 |
205,941,215 |
RGD:6480464 |
CTD |
| G |
Gcfc2 |
GC-rich sequence DNA-binding factor 2 |
|
decreases expression |
ISO |
4 |
116,167,383 |
116,204,212 |
RGD:6480464 |
CTD |
| G |
Gdap2 |
ganglioside-induced differentiation-associated-protein 2 |
|
increases expression |
ISO |
2 |
195,116,710 |
195,174,436 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
decreases expression |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
multiple interactions |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
multiple interactions |
EXP |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gtf2h1 |
general transcription factor IIH, polypeptide 1 |
|
decreases expression |
ISO |
1 |
97,352,251 |
97,380,298 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
increases expression |
ISO |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Hfe |
hemochromatosis |
|
affects abundance |
ISO |
17 |
48,469,927 |
48,478,502 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1an |
hypoxia-inducible factor 1, alpha subunit inhibitor |
|
decreases expression |
ISO |
1 |
249,607,945 |
249,618,000 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases activity |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
decreases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
multiple interactions |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htt |
huntingtin |
|
decreases uptake |
ISO |
14 |
81,490,322 |
81,636,856 |
RGD:6480464 |
CTD |
| G |
Htt |
huntingtin |
|
decreases abundance |
ISO |
14 |
81,490,322 |
81,636,856 |
RGD:6480464 |
CTD |
| G |
Htt |
huntingtin |
|
decreases response to substance |
ISO |
14 |
81,490,322 |
81,636,856 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
|
affects binding |
ISO |
8 |
58,135,412 |
58,156,019 |
RGD:6480464 |
CTD |
| G |
Idh3g |
isocitrate dehydrogenase 3 (NAD), gamma |
|
affects binding |
ISO |
X |
159,701,345 |
159,710,254 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
increases expression |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il7 |
interleukin 7 |
|
increases expression |
ISO |
2 |
96,356,083 |
96,399,796 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
multiple interactions |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Ipo11 |
importin 11 |
|
decreases expression |
ISO |
2 |
38,006,409 |
38,054,430 |
RGD:6480464 |
CTD |
| G |
Ireb2 |
iron responsive element binding protein 2 |
|
decreases activity |
EXP |
8 |
58,433,218 |
58,477,305 |
RGD:6480464 |
CTD |
| G |
Ireb2 |
iron responsive element binding protein 2 |
|
increases expression |
EXP |
8 |
58,433,218 |
58,477,305 |
RGD:6480464 |
CTD |
| G |
Irs4 |
insulin receptor substrate 4 |
|
multiple interactions |
EXP |
X |
36,881,414 |
36,885,105 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
increases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
increases expression |
EXP |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases activity |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases activity |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
|
multiple interactions |
ISO |
16 |
6,364,102 |
6,378,251 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
multiple interactions |
ISO |
1 |
96,614,960 |
96,617,993 |
RGD:6480464 |
CTD |
| G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
increases expression |
ISO |
3 |
37,068,672 |
37,256,990 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
decreases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Lefty2 |
Left-right determination factor 2 |
|
decreases expression |
ISO |
13 |
96,621,422 |
96,626,509 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases abundance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lman2 |
lectin, mannose-binding 2 |
|
increases expression |
ISO |
17 |
15,313,291 |
15,331,470 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
multiple interactions |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
decreases phosphorylation |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
|
multiple interactions |
EXP |
10 |
92,406,098 |
92,456,276 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
increases expression |
ISO |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
increases expression |
ISO |
7 |
119,557,141 |
119,559,619 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
decreases expression |
ISO |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
decreases expression |
ISO |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
|
increases expression |
ISO |
1 |
146,220,504 |
146,422,659 |
RGD:6480464 |
CTD |
| G |
Mia |
melanoma inhibitory activity |
|
increases expression |
ISO |
1 |
82,255,458 |
82,257,125 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
decreases expression |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
decreases expression |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Mtm1 |
myotubularin 1 |
|
decreases expression |
ISO |
7 |
247,960 |
265,281 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Myom1 |
myomesin 1 |
|
increases expression |
ISO |
9 |
110,218,668 |
110,341,029 |
RGD:6480464 |
CTD |
| G |
Myt1l |
myelin transcription factor 1-like |
|
increases expression |
ISO |
6 |
47,435,167 |
47,828,030 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
increases expression |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
increases expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
increases expression |
ISO |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
decreases expression |
ISO |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfyb |
nuclear transcription factor-Y beta |
|
decreases expression |
ISO |
7 |
23,190,295 |
23,205,611 |
RGD:6480464 |
CTD |
| G |
Nmt1 |
N-myristoyltransferase 1 |
|
multiple interactions |
ISO |
10 |
92,196,640 |
92,230,571 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases activity |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch4 |
notch 4 |
|
decreases expression |
ISO |
20 |
4,263,205 |
4,287,312 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
decreases expression |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases activity |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nrg2 |
neuregulin 2 |
|
increases expression |
ISO |
18 |
28,650,097 |
28,828,772 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
increases expression |
ISO |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
decreases expression |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
|
decreases expression |
ISO |
6 |
142,904,062 |
142,905,783 |
RGD:6480464 |
CTD |
| G |
Nudt9 |
nudix (nucleoside diphosphate linked moiety X)-type motif 9 |
|
multiple interactions |
ISO |
14 |
6,809,091 |
6,840,664 |
RGD:6480464 |
CTD |
| G |
Nudt9 |
nudix (nucleoside diphosphate linked moiety X)-type motif 9 |
|
increases activity |
ISO |
14 |
6,809,091 |
6,840,664 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
decreases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Olfm1 |
olfactomedin 1 |
|
increases expression |
ISO |
3 |
7,170,421 |
7,195,345 |
RGD:6480464 |
CTD |
| G |
Oprd1 |
opioid receptor, delta 1 |
|
multiple interactions |
EXP |
5 |
150,979,252 |
151,014,066 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
multiple interactions |
EXP |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pappa |
pregnancy-associated plasma protein A |
|
increases expression |
ISO |
5 |
81,826,649 |
82,096,446 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
decreases transport |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
affects response to substance |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
increases expression |
EXP |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
decreases expression |
EXP |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
increases expression |
ISO |
14 |
56,609,036 |
57,323,892 |
RGD:6480464 |
CTD |
| G |
Pcdha6 |
protocadherin alpha 6 |
|
increases expression |
ISO |
18 |
29,697,876 |
29,928,030 |
RGD:6480464 |
CTD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
increases expression |
ISO |
3 |
54,292,076 |
54,319,242 |
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
increases expression |
ISO |
6 |
109,215,540 |
109,226,122 |
RGD:6480464 |
CTD |
| G |
Phtf1 |
putative homeodomain transcription factor 1 |
|
decreases expression |
ISO |
2 |
199,202,647 |
199,241,476 |
RGD:6480464 |
CTD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
increases expression |
ISO |
1 |
242,794,858 |
243,103,437 |
RGD:6480464 |
CTD |
| G |
Pln |
phospholamban |
|
decreases expression |
ISO |
20 |
32,000,371 |
32,008,559 |
RGD:6480464 |
CTD |
| G |
Pou1f1 |
POU class 1 homeobox 1 |
|
increases expression |
ISO |
11 |
2,959,383 |
2,980,545 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
increases phosphorylation |
EXP |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Prim2 |
primase, DNA, polypeptide 2 |
|
decreases expression |
ISO |
9 |
32,206,274 |
32,424,970 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases phosphorylation |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases phosphorylation |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
increases expression |
ISO |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
increases stability |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
multiple interactions |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
affects binding |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
decreases expression |
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Ptx3 |
pentraxin 3, long |
|
increases expression |
ISO |
2 |
156,089,917 |
156,095,726 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
decreases expression |
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Rab21 |
RAB21, member RAS oncogene family |
|
decreases expression |
ISO |
7 |
54,550,247 |
54,575,032 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
decreases expression |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rfc5 |
replication factor C (activator 1) 5 |
|
decreases expression |
ISO |
12 |
40,395,942 |
40,405,498 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rgs5 |
regulator of G-protein signaling 5 |
|
decreases expression |
ISO |
13 |
85,445,325 |
85,482,294 |
RGD:6480464 |
CTD |
| G |
Rgs6 |
regulator of G-protein signaling 6 |
|
increases expression |
ISO |
6 |
106,470,420 |
106,964,581 |
RGD:6480464 |
CTD |
| G |
Rnf145 |
ring finger protein 145 |
|
increases expression |
ISO |
10 |
29,680,833 |
29,720,064 |
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
decreases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
increases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
decreases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
increases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
increases expression |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
Scn3b |
sodium channel, voltage-gated, type III, beta |
|
increases expression |
ISO |
8 |
43,231,453 |
43,254,066 |
RGD:6480464 |
CTD |
| G |
Sdcbp2 |
syndecan binding protein (syntenin) 2 |
|
decreases expression |
ISO |
3 |
141,891,232 |
141,919,905 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
increases expression |
ISO |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sfxn5 |
sideroflexin 5 |
|
increases expression |
ISO |
4 |
119,462,697 |
119,583,363 |
RGD:6480464 |
CTD |
| G |
Sirt2 |
sirtuin 2 |
|
increases expression |
ISO |
1 |
83,873,578 |
83,896,121 |
RGD:6480464 |
CTD |
| G |
Six3 |
SIX homeobox 3 |
|
increases expression |
ISO |
6 |
8,981,995 |
9,019,365 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases uptake |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases metabolic processing |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc16a3 |
solute carrier family 16, member 3 (monocarboxylic acid transporter 4) |
|
increases expression |
ISO |
10 |
110,159,679 |
110,163,182 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
decreases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
multiple interactions |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
decreases expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
multiple interactions |
EXP |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc22a15 |
solute carrier family 22, member 15 |
|
decreases expression |
ISO |
2 |
196,953,291 |
197,013,763 |
RGD:6480464 |
CTD |
| G |
Slc2a13 |
solute carrier family 2 (facilitated glucose transporter), member 13 |
|
increases expression |
ISO |
7 |
129,682,782 |
130,005,752 |
RGD:6480464 |
CTD |
| G |
Slc38a1 |
solute carrier family 38, member 1 |
|
decreases expression |
EXP |
7 |
135,252,257 |
135,316,256 |
RGD:6480464 |
CTD |
| G |
Slc38a10 |
solute carrier family 38, member 10 |
|
increases expression |
ISO |
10 |
109,516,004 |
109,569,804 |
RGD:6480464 |
CTD |
| G |
Slc38a3 |
solute carrier family 38, member 3 |
|
multiple interactions |
EXP |
8 |
112,898,405 |
112,914,444 |
RGD:6480464 |
CTD |
| G |
Slc38a3 |
solute carrier family 38, member 3 |
|
decreases expression |
EXP |
8 |
112,898,405 |
112,914,444 |
RGD:6480464 |
CTD |
| G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
|
increases expression |
ISO |
15 |
50,703,198 |
50,749,644 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
multiple interactions |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
increases uptake |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc4a10 |
solute carrier family 4, sodium bicarbonate transporter, member 10 |
|
decreases expression |
ISO |
3 |
43,979,103 |
44,274,283 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
increases expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Smim14 |
small integral membrane protein 14 |
|
increases expression |
ISO |
14 |
45,477,213 |
45,520,785 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases uptake |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sort1 |
sortilin 1 |
|
decreases expression |
ISO |
2 |
203,853,009 |
203,931,559 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
EXP |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spa17 |
sperm autoantigenic protein 17 |
|
decreases expression |
ISO |
8 |
38,843,007 |
38,852,080 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Stox1 |
storkhead box 1 |
|
decreases expression |
ISO |
20 |
29,904,966 |
29,977,218 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Syn1 |
synapsin I |
|
increases phosphorylation |
EXP |
X |
12,512,241 |
12,556,160 |
RGD:6480464 |
CTD |
| G |
Tab1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
|
affects binding |
ISO |
7 |
118,368,997 |
118,402,928 |
RGD:6480464 |
CTD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
decreases expression |
ISO |
4 |
116,610,595 |
116,780,394 |
RGD:6480464 |
CTD |
| G |
Tagln2 |
transgelin 2 |
|
decreases expression |
ISO |
13 |
88,505,258 |
88,512,178 |
RGD:6480464 |
CTD |
| G |
Tbx18 |
T-box18 |
|
increases expression |
ISO |
8 |
92,984,336 |
93,012,343 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
increases uptake |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
affects binding |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
multiple interactions |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
affects binding |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
multiple interactions |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfap2b |
transcription factor AP-2 beta |
|
increases expression |
ISO |
9 |
18,052,402 |
18,082,202 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
increases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnrc6a |
trinucleotide repeat containing 6a |
|
increases expression |
ISO |
1 |
181,982,994 |
182,053,510 |
RGD:6480464 |
CTD |
| G |
Tpcn1 |
two pore segment channel 1 |
|
increases expression |
ISO |
12 |
37,140,428 |
37,227,711 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases uptake |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpm1 |
transient receptor potential cation channel, subfamily M, member 1 |
|
increases expression |
ISO |
1 |
118,583,516 |
118,700,653 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
increases expression |
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
increases uptake |
EXP |
3 |
114,320,799 |
114,410,498 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
decreases expression |
ISO |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Tsga10 |
testis specific 10 |
|
increases expression |
ISO |
9 |
36,713,297 |
36,811,661 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
decreases expression |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
decreases expression |
EXP |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Ucn |
urocortin |
|
multiple interactions |
EXP |
6 |
25,216,788 |
25,217,618 |
RGD:6480464 |
CTD |
| G |
Usp15 |
ubiquitin specific peptidase 15 |
|
decreases expression |
ISO |
7 |
62,871,167 |
62,961,405 |
RGD:6480464 |
CTD |
| G |
Usp45 |
ubiquitin specific peptidase 45 |
|
decreases expression |
ISO |
5 |
36,517,213 |
36,590,986 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
increases expression |
ISO |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vps13a |
vacuolar protein sorting 13 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
219,987,826 |
220,221,494 |
RGD:6480464 |
CTD |
| G |
Wt1 |
Wilms tumor 1 |
|
decreases expression |
ISO |
3 |
90,529,704 |
90,577,280 |
RGD:6480464 |
CTD |
| G |
Zfp41 |
zinc finger protein 41 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
maneb
|
| G |
Ache |
acetylcholinesterase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ache |
acetylcholinesterase |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adam22 |
ADAM metallopeptidase domain 22 |
|
multiple interactions |
ISO |
4 |
22,332,086 |
22,507,086 |
RGD:6480464 |
CTD |
| G |
Ago3 |
argonaute RISC catalytic component 3 |
|
multiple interactions |
ISO |
5 |
145,713,438 |
145,779,165 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
decreases activity |
EXP |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
|
decreases activity |
EXP |
17 |
47,193,407 |
47,216,499 |
RGD:6480464 |
CTD |
| G |
Amn |
amnion associated transmembrane protein |
|
multiple interactions |
ISO |
6 |
136,031,478 |
136,038,919 |
RGD:6480464 |
CTD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 (Fe65) |
|
multiple interactions |
ISO |
1 |
163,282,918 |
163,299,333 |
RGD:6480464 |
CTD |
| G |
Arnt2 |
aryl hydrocarbon receptor nuclear translocator 2 |
|
multiple interactions |
ISO |
1 |
140,535,823 |
140,646,838 |
RGD:6480464 |
CTD |
| G |
Ascl1 |
achaete-scute complex homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
7 |
24,145,578 |
24,168,494 |
RGD:6480464 |
CTD |
| G |
Atg12 |
autophagy related 12 |
|
multiple interactions |
ISO |
18 |
40,933,793 |
40,943,970 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bai1 |
brain-specific angiogenesis inhibitor 1 |
|
multiple interactions |
ISO |
7 |
112,622,235 |
112,682,897 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
increases expression |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bicd1 |
bicaudal D homolog 1 (Drosophila) |
|
multiple interactions |
ISO |
4 |
186,922,060 |
187,069,288 |
RGD:6480464 |
CTD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
multiple interactions |
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
ISO |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
Cacna1e |
calcium channel, voltage-dependent, R type, alpha 1E subunit |
|
multiple interactions |
ISO |
13 |
69,367,254 |
69,683,943 |
RGD:6480464 |
CTD |
| G |
Camp |
cathelicidin antimicrobial peptide |
|
multiple interactions |
ISO |
8 |
114,214,914 |
114,216,728 |
RGD:6480464 |
CTD |
| G |
Capn11 |
calpain 11 |
|
multiple interactions |
ISO |
9 |
10,944,080 |
10,965,592 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Ccdc88a |
coiled coil domain containing 88A |
|
multiple interactions |
ISO |
14 |
110,376,486 |
110,525,468 |
RGD:6480464 |
CTD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
multiple interactions |
ISO |
5 |
59,221,738 |
59,223,682 |
RGD:6480464 |
CTD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
multiple interactions |
ISO |
5 |
59,238,897 |
59,240,001 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Cdhr4 |
cadherin-related family member 4 |
|
multiple interactions |
ISO |
8 |
113,262,207 |
113,269,894 |
RGD:6480464 |
CTD |
| G |
Cdk5r1 |
cyclin-dependent kinase 5, regulatory subunit 1 (p35) |
|
multiple interactions |
ISO |
10 |
68,715,844 |
68,717,045 |
RGD:6480464 |
CTD |
| G |
Cdk5rap1 |
CDK5 regulatory subunit associated protein 1 |
|
multiple interactions |
ISO |
3 |
144,803,213 |
144,840,056 |
RGD:6480464 |
CTD |
| G |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
|
multiple interactions |
ISO |
5 |
87,564,010 |
87,738,257 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cep290 |
centrosomal protein 290 |
|
multiple interactions |
ISO |
7 |
38,138,545 |
38,228,716 |
RGD:6480464 |
CTD |
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
multiple interactions |
ISO |
4 |
63,911,292 |
63,913,354 |
RGD:6480464 |
CTD |
| G |
Cplx1 |
complexin 1 |
|
multiple interactions |
ISO |
14 |
1,732,344 |
1,763,172 |
RGD:6480464 |
CTD |
| G |
Crlf2 |
cytokine receptor-like factor 2 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
multiple interactions |
EXP |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
decreases expression |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
multiple interactions |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
decreases activity |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases activity |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
EXP |
1 |
200,918,521 |
200,928,919 |
RGD:6480464 |
CTD |
| G |
Dgki |
diacylglycerol kinase, iota |
|
multiple interactions |
ISO |
4 |
64,207,192 |
64,663,627 |
RGD:6480464 |
CTD |
| G |
Dip2b |
DIP2 disco-interacting protein 2 homolog B (Drosophila) |
|
multiple interactions |
ISO |
7 |
138,782,124 |
138,958,414 |
RGD:6480464 |
CTD |
| G |
Dll1 |
delta-like 1 (Drosophila) |
|
multiple interactions |
ISO |
1 |
54,240,395 |
54,248,183 |
RGD:6480464 |
CTD |
| G |
Dmrta2 |
DMRT-like family A2 |
|
multiple interactions |
ISO |
5 |
131,410,451 |
131,416,198 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Drd4 |
dopamine receptor D4 |
|
multiple interactions |
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:6480464 |
CTD |
| G |
Drd5 |
dopamine receptor D5 |
|
multiple interactions |
ISO |
14 |
77,768,060 |
77,769,487 |
RGD:6480464 |
CTD |
| G |
Efnb1 |
ephrin B1 |
|
multiple interactions |
ISO |
X |
87,163,176 |
87,175,982 |
RGD:6480464 |
CTD |
| G |
Egr4 |
early growth response 4 |
|
multiple interactions |
ISO |
4 |
119,765,289 |
119,767,612 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
multiple interactions |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Etl4 |
enhancer trap locus 4 |
|
multiple interactions |
ISO |
17 |
94,757,415 |
94,770,668 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
multiple interactions |
ISO |
8 |
38,078,328 |
38,123,983 |
RGD:6480464 |
CTD |
| G |
Gabra6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
|
multiple interactions |
ISO |
10 |
27,474,071 |
27,489,074 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
ISO |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases activity |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gh1 |
growth hormone 1 |
|
multiple interactions |
ISO |
10 |
95,692,240 |
95,694,117 |
RGD:6480464 |
CTD |
| G |
Gmfb |
glia maturation factor, beta |
|
multiple interactions |
ISO |
15 |
22,664,728 |
22,675,100 |
RGD:6480464 |
CTD |
| G |
Gngt2 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
|
multiple interactions |
ISO |
10 |
84,554,318 |
84,557,459 |
RGD:6480464 |
CTD |
| G |
Gpr27 |
G protein-coupled receptor 27 |
|
multiple interactions |
ISO |
4 |
134,541,534 |
134,542,667 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsk3b |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
11 |
64,284,731 |
64,428,698 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsta3 |
glutathione S-transferase alpha 3 |
|
increases expression |
EXP |
9 |
20,005,570 |
20,032,031 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases activity |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
ISO |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
increases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Hdac3 |
histone deacetylase 3 |
|
decreases activity |
ISO |
18 |
30,857,209 |
30,875,986 |
RGD:6480464 |
CTD |
| G |
Hdac6 |
histone deacetylase 6 |
|
decreases activity |
ISO |
X |
26,585,852 |
26,606,999 |
RGD:6480464 |
CTD |
| G |
Hes3 |
hairy and enhancer of split 3 (Drosophila) |
|
multiple interactions |
ISO |
5 |
169,516,965 |
169,518,859 |
RGD:6480464 |
CTD |
| G |
Hey2 |
hairy/enhancer-of-split related with YRPW motif 2 |
|
multiple interactions |
ISO |
1 |
27,505,117 |
27,515,204 |
RGD:6480464 |
CTD |
| G |
Hist1h2bh |
histone cluster 1, H2bh |
|
multiple interactions |
ISO |
17 |
50,111,215 |
50,111,595 |
RGD:6480464 |
CTD |
| G |
Hist2h2ac |
histone cluster 2, H2ac |
|
multiple interactions |
ISO |
2 |
191,023,502 |
191,023,891 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
|
decreases activity |
ISO |
19 |
35,336,342 |
35,341,585 |
RGD:6480464 |
CTD |
| G |
Ier5l |
immediate early response 5-like |
|
multiple interactions |
ISO |
3 |
9,515,947 |
9,517,538 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Itgb8 |
integrin, beta 8 |
|
multiple interactions |
ISO |
6 |
146,494,978 |
146,573,064 |
RGD:6480464 |
CTD |
| G |
Kcna2 |
potassium voltage-gated channel, shaker-related subfamily, member 2 |
|
multiple interactions |
ISO |
2 |
202,560,152 |
202,564,305 |
RGD:6480464 |
CTD |
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
multiple interactions |
ISO |
15 |
575,136 |
950,275 |
RGD:6480464 |
CTD |
| G |
Kif1b |
kinesin family member 1B |
|
multiple interactions |
ISO |
5 |
166,250,225 |
166,381,782 |
RGD:6480464 |
CTD |
| G |
Klf2 |
Kruppel-like factor 2 (lung) |
|
multiple interactions |
ISO |
16 |
17,941,780 |
17,943,730 |
RGD:6480464 |
CTD |
| G |
Klhl15 |
kelch-like family member 15 |
|
multiple interactions |
ISO |
X |
81,629,200 |
81,679,937 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
multiple interactions |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lifr |
leukemia inhibitory factor receptor alpha |
|
multiple interactions |
ISO |
2 |
56,426,058 |
56,477,198 |
RGD:6480464 |
CTD |
| G |
Lor |
loricrin |
|
multiple interactions |
ISO |
2 |
184,953,538 |
184,955,283 |
RGD:6480464 |
CTD |
| G |
Lrp4 |
low density lipoprotein receptor-related protein 4 |
|
multiple interactions |
ISO |
3 |
75,821,638 |
75,875,100 |
RGD:6480464 |
CTD |
| G |
Lrrk2 |
leucine-rich repeat kinase 2 |
|
multiple interactions |
ISO |
7 |
130,105,902 |
130,267,747 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk15 |
mitogen-activated protein kinase 15 |
|
multiple interactions |
ISO |
7 |
114,026,694 |
114,032,007 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mboat2 |
membrane bound O-acyltransferase domain containing 2 |
|
multiple interactions |
ISO |
6 |
42,486,112 |
42,608,004 |
RGD:6480464 |
CTD |
| G |
Muc6 |
mucin 6, oligomeric mucus/gel-forming |
|
multiple interactions |
ISO |
1 |
201,815,833 |
201,837,239 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
multiple interactions |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
increases expression |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
multiple interactions |
ISO |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Ngp |
neutrophilic granule protein |
|
multiple interactions |
ISO |
8 |
114,795,567 |
114,798,934 |
RGD:6480464 |
CTD |
| G |
Nipbl |
Nipped-B homolog (Drosophila) |
|
multiple interactions |
ISO |
2 |
57,908,828 |
58,099,422 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nps |
neuropeptide S |
|
multiple interactions |
ISO |
1 |
194,887,958 |
194,892,866 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
ISO |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
ISO |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Pax6 |
paired box 6 |
|
multiple interactions |
ISO |
3 |
91,127,605 |
91,149,178 |
RGD:6480464 |
CTD |
| G |
Pcp2 |
Purkinje cell protein 2 |
|
multiple interactions |
ISO |
12 |
2,529,953 |
2,531,706 |
RGD:6480464 |
CTD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
multiple interactions |
ISO |
1 |
242,794,858 |
243,103,437 |
RGD:6480464 |
CTD |
| G |
Prdx1 |
peroxiredoxin 1 |
|
increases expression |
ISO |
5 |
136,975,780 |
136,991,630 |
RGD:6480464 |
CTD |
| G |
Prdx1l1 |
peroxiredoxin 1-like 1 |
|
increases expression |
ISO |
2 |
201,373,420 |
201,374,019 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prr7 |
proline rich 7 (synaptic) |
|
multiple interactions |
ISO |
17 |
15,209,243 |
15,210,367 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
multiple interactions |
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Rock1 |
Rho-associated coiled-coil containing protein kinase 1 |
|
multiple interactions |
ISO |
18 |
1,391,751 |
1,511,865 |
RGD:6480464 |
CTD |
| G |
Rtn4rl2 |
reticulon 4 receptor-like 2 |
|
multiple interactions |
ISO |
3 |
68,098,435 |
68,113,874 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
multiple interactions |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100a9 |
S100 calcium binding protein A9 |
|
multiple interactions |
ISO |
2 |
182,985,466 |
182,988,147 |
RGD:6480464 |
CTD |
| G |
Scand1 |
SCAN domain-containing 1 |
|
multiple interactions |
ISO |
3 |
146,710,153 |
146,711,017 |
RGD:6480464 |
CTD |
| G |
Sirt1 |
sirtuin 1 |
|
decreases activity |
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:6480464 |
CTD |
| G |
Sirt2 |
sirtuin 2 |
|
decreases activity |
ISO |
1 |
83,873,578 |
83,896,121 |
RGD:6480464 |
CTD |
| G |
Sirt3 |
sirtuin 3 |
|
decreases activity |
ISO |
1 |
201,021,391 |
201,043,756 |
RGD:6480464 |
CTD |
| G |
Slc17a8 |
solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8 |
|
multiple interactions |
ISO |
7 |
26,361,488 |
26,413,820 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
ISO |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc5a7 |
solute carrier family 5 (choline transporter), member 7 |
|
multiple interactions |
ISO |
9 |
133,838 |
165,943 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
multiple interactions |
ISO |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
affects response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc8a1 |
solute carrier family 8 (sodium/calcium exchanger), member 1 |
|
multiple interactions |
ISO |
6 |
4,421,046 |
4,691,716 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Ston2 |
stonin 2 |
|
multiple interactions |
ISO |
6 |
115,258,140 |
115,369,129 |
RGD:6480464 |
CTD |
| G |
Strbp |
spermatid perinuclear RNA binding protein |
|
multiple interactions |
ISO |
3 |
17,338,337 |
17,411,975 |
RGD:6480464 |
CTD |
| G |
Tbck |
TBC1 domain containing kinase |
|
multiple interactions |
ISO |
2 |
230,166,553 |
230,336,937 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tmem42 |
transmembrane protein 42 |
|
multiple interactions |
ISO |
8 |
127,767,070 |
127,769,567 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnr |
tenascin R |
|
multiple interactions |
ISO |
13 |
75,271,116 |
75,347,181 |
RGD:6480464 |
CTD |
| G |
Trpm3 |
transient receptor potential cation channel, subfamily M, member 3 |
|
multiple interactions |
ISO |
1 |
225,377,097 |
226,276,992 |
RGD:6480464 |
CTD |
| G |
Tusc1 |
tumor suppressor candidate 1 |
|
multiple interactions |
ISO |
5 |
113,414,632 |
113,416,295 |
RGD:6480464 |
CTD |
| G |
Txn1 |
thioredoxin 1 |
|
increases expression |
ISO |
5 |
75,921,365 |
75,933,595 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
increases expression |
ISO |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Unc13c |
unc-13 homolog C (C. elegans) |
|
multiple interactions |
ISO |
8 |
78,278,728 |
78,703,566 |
RGD:6480464 |
CTD |
| G |
Zbtb44 |
zinc finger and BTB domain containing 44 |
|
multiple interactions |
ISO |
8 |
30,841,899 |
30,894,133 |
RGD:6480464 |
CTD |
| G |
Zfp580 |
zinc finger protein 580 |
|
multiple interactions |
ISO |
1 |
67,525,765 |
67,527,928 |
RGD:6480464 |
CTD |
| G |
Zhx3 |
zinc fingers and homeoboxes 3 |
|
multiple interactions |
ISO |
3 |
151,560,440 |
151,574,257 |
RGD:6480464 |
CTD |
manganese(0)
|
| G |
Abca5 |
ATP-binding cassette, subfamily A (ABC1), member 5 |
|
decreases expression |
ISO |
10 |
99,724,778 |
99,793,593 |
RGD:6480464 |
CTD |
| G |
Abca9 |
ATP-binding cassette, subfamily A (ABC1), member 9 |
|
increases expression |
ISO |
10 |
99,558,803 |
99,619,870 |
RGD:6480464 |
CTD |
| G |
Abcc6 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 6 |
|
multiple interactions |
EXP |
1 |
96,448,588 |
96,524,655 |
RGD:6480464 |
CTD |
| G |
Abi2 |
abl-interactor 2 |
|
increases expression |
ISO |
9 |
59,028,651 |
59,079,887 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
decreases activity |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases activity |
ISO |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases activity |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
multiple interactions |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases activity |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases expression |
ISO |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
multiple interactions |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Aco2 |
aconitase 2, mitochondrial |
|
decreases activity |
EXP |
7 |
120,223,788 |
120,266,944 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:6480464 |
CTD |
| G |
Akap7 |
A kinase (PRKA) anchor protein 7 |
|
decreases expression |
ISO |
1 |
20,573,215 |
20,704,564 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
increases expression |
ISO |
7 |
16,261,623 |
16,267,852 |
RGD:6480464 |
CTD |
| G |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
|
increases expression |
ISO |
1 |
137,672,485 |
137,675,472 |
RGD:6480464 |
CTD |
| G |
Apol2 |
apolipoprotein L, 2 |
|
increases expression |
ISO |
7 |
115,668,899 |
115,673,029 |
RGD:6480464 |
CTD |
| G |
App |
amyloid beta (A4) precursor protein |
|
increases expression |
ISO |
11 |
24,457,855 |
24,693,851 |
RGD:6480464 |
CTD |
| G |
Aqp4 |
aquaporin 4 |
|
multiple interactions |
EXP |
18 |
6,626,313 |
6,642,766 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects binding |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
affects binding |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
decreases expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arhgef4 |
Rho guanine nucleotide exchange factor (GEF) 4 |
|
increases expression |
ISO |
9 |
33,395,974 |
33,539,597 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
increases phosphorylation |
EXP |
7 |
138,971,063 |
139,014,690 |
RGD:6480464 |
CTD |
| G |
Atf1 |
activating transcription factor 1 |
|
multiple interactions |
EXP |
7 |
138,971,063 |
139,014,690 |
RGD:6480464 |
CTD |
| G |
Atf6 |
activating transcription factor 6 |
|
decreases expression |
ISO |
13 |
86,543,773 |
86,718,970 |
RGD:6480464 |
CTD |
| G |
Atm |
ataxia telangiectasia mutated |
|
decreases expression |
ISO |
8 |
56,894,746 |
56,996,565 |
RGD:6480464 |
CTD |
| G |
Atp13a2 |
ATPase type 13A2 |
|
affects response to substance |
ISO |
5 |
159,847,016 |
159,866,362 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
increases phosphorylation |
ISO |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Atp8a1 |
ATPase, aminophospholipid transporter (APLT), class I, type 8A, member 1 |
|
decreases expression |
ISO |
14 |
42,923,309 |
43,165,666 |
RGD:6480464 |
CTD |
| G |
Bace1 |
beta-site APP cleaving enzyme 1 |
|
increases expression |
ISO |
8 |
48,817,824 |
48,839,681 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bnip3 |
BCL2/adenovirus E1B interacting protein 3 |
|
multiple interactions |
ISO |
1 |
198,683,009 |
198,700,075 |
RGD:6480464 |
CTD |
| G |
Bub1 |
BUB1 mitotic checkpoint serine/threonine kinase |
|
decreases expression |
ISO |
3 |
115,323,510 |
115,354,906 |
RGD:6480464 |
CTD |
| G |
Calcoco2 |
calcium binding and coiled-coil domain 2 |
|
increases expression |
ISO |
10 |
84,820,832 |
84,847,065 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp7 |
caspase 7 |
|
increases activity |
EXP |
1 |
262,689,300 |
262,721,591 |
RGD:6480464 |
CTD |
| G |
Casp9 |
caspase 9, apoptosis-related cysteine peptidase |
|
increases cleavage |
EXP |
5 |
160,704,234 |
160,721,796 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
EXP |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
ISO |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccnb2 |
cyclin B2 |
|
decreases expression |
ISO |
8 |
74,892,108 |
74,906,181 |
RGD:6480464 |
CTD |
| G |
Cd48 |
Cd48 molecule |
|
increases expression |
ISO |
13 |
87,684,545 |
87,708,091 |
RGD:6480464 |
CTD |
| G |
Cd8b |
CD8b molecule |
|
increases expression |
ISO |
4 |
104,536,454 |
104,552,683 |
RGD:6480464 |
CTD |
| G |
Cdkn2c |
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) |
|
decreases expression |
ISO |
5 |
131,012,524 |
131,017,679 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
ISO |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Celsr1 |
cadherin, EGF LAG seven-pass G-type receptor 1 |
|
increases expression |
ISO |
7 |
123,900,366 |
124,036,122 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
decreases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
|
decreases expression |
ISO |
7 |
55,823,982 |
55,880,812 |
RGD:6480464 |
CTD |
| G |
Cnot6l |
CCR4-NOT transcription complex, subunit 6-like |
|
increases expression |
ISO |
14 |
14,924,620 |
15,011,984 |
RGD:6480464 |
CTD |
| G |
Col12a1 |
collagen, type XII, alpha 1 |
|
decreases expression |
ISO |
8 |
84,641,358 |
84,756,923 |
RGD:6480464 |
CTD |
| G |
Cpm |
carboxypeptidase M |
|
decreases expression |
ISO |
7 |
56,931,920 |
56,992,248 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
EXP |
9 |
63,170,785 |
63,234,727 |
RGD:6480464 |
CTD |
| G |
Ctnna1 |
catenin (cadherin-associated protein), alpha 1, 102kDa |
|
decreases expression |
ISO |
18 |
27,629,915 |
27,769,360 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
decreases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
increases expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
EXP |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cxcl3 |
chemokine (C-X-C motif) ligand 3 |
|
increases expression |
ISO |
14 |
18,767,306 |
18,787,340 |
RGD:6480464 |
CTD |
| G |
Cyp2d3 |
cytochrome P450, family 2, subfamily d, polypeptide 3 |
|
decreases response to substance |
ISO |
7 |
120,778,783 |
120,783,140 |
RGD:6480464 |
CTD |
| G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
|
decreases response to substance |
ISO |
7 |
120,742,273 |
120,752,274 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
increases activity |
EXP |
5 |
19,707,159 |
19,716,856 |
RGD:6480464 |
CTD |
| G |
Dach2 |
dachshund homolog 2 (Drosophila) |
|
increases expression |
ISO |
X |
102,020,017 |
102,585,398 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
decreases expression |
ISO |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
multiple interactions |
ISO |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
|
decreases expression |
ISO |
9 |
9,865,096 |
9,867,833 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
increases expression |
ISO |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dr1 |
down-regulator of transcription 1 |
|
decreases expression |
ISO |
14 |
2,005,938 |
2,017,291 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
decreases expression |
EXP |
8 |
52,641,160 |
52,707,749 |
RGD:6480464 |
CTD |
| G |
Dspp |
dentin sialophosphoprotein |
|
increases expression |
ISO |
14 |
6,674,662 |
6,680,769 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
multiple interactions |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
decreases expression |
ISO |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Eif2a |
eukaryotic translation initiation factor 2A |
|
increases expression |
ISO |
2 |
147,870,265 |
147,903,411 |
RGD:6480464 |
CTD |
| G |
Elf1 |
E74-like factor 1 |
|
decreases expression |
ISO |
15 |
60,793,794 |
60,835,189 |
RGD:6480464 |
CTD |
| G |
Eml2 |
echinoderm microtubule associated protein like 2 |
|
increases expression |
ISO |
1 |
78,539,321 |
78,570,125 |
RGD:6480464 |
CTD |
| G |
Emr1 |
EGF-like module containing, mucin-like, hormone receptor-like 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Epo |
erythropoietin |
|
increases glycosylation |
ISO |
12 |
19,551,768 |
19,555,208 |
RGD:6480464 |
CTD |
| G |
Ercc6l |
excision repair cross-complementing rodent repair deficiency complementation group 6 - like |
|
decreases expression |
ISO |
X |
90,195,080 |
90,212,006 |
RGD:6480464 |
CTD |
| G |
Ereg |
epiregulin |
|
increases expression |
ISO |
14 |
18,521,069 |
18,534,844 |
RGD:6480464 |
CTD |
| G |
Erich1 |
glutamate-rich 1 |
|
increases expression |
ISO |
16 |
80,333,204 |
80,404,945 |
RGD:6480464 |
CTD |
| G |
Exoc6 |
exocyst complex component 6 |
|
decreases expression |
ISO |
1 |
241,964,047 |
242,008,416 |
RGD:6480464 |
CTD |
| G |
Eya4 |
eyes absent homolog 4 (Drosophila) |
|
decreases expression |
ISO |
1 |
22,814,568 |
22,914,973 |
RGD:6480464 |
CTD |
| G |
Fancf |
Fanconi anemia, complementation group F |
|
decreases expression |
ISO |
1 |
101,664,895 |
101,666,720 |
RGD:6480464 |
CTD |
| G |
Fhl1 |
four and a half LIM domains 1 |
|
decreases expression |
ISO |
X |
141,315,765 |
141,329,278 |
RGD:6480464 |
CTD |
| G |
Flcn |
folliculin |
|
increases expression |
ISO |
10 |
46,110,527 |
46,129,613 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Foxp2 |
forkhead box P2 |
|
increases expression |
ISO |
4 |
40,719,812 |
40,977,517 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
increases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
EXP |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fxyd2 |
FXYD domain-containing ion transport regulator 2 |
|
increases expression |
ISO |
8 |
48,379,075 |
48,385,553 |
RGD:6480464 |
CTD |
| G |
Gabrg2 |
gamma-aminobutyric acid (GABA) A receptor, gamma 2 |
|
increases expression |
ISO |
10 |
27,037,561 |
27,126,074 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
increases expression |
ISO |
1 |
205,936,352 |
205,941,215 |
RGD:6480464 |
CTD |
| G |
Gcfc2 |
GC-rich sequence DNA-binding factor 2 |
|
decreases expression |
ISO |
4 |
116,167,383 |
116,204,212 |
RGD:6480464 |
CTD |
| G |
Gdap2 |
ganglioside-induced differentiation-associated-protein 2 |
|
increases expression |
ISO |
2 |
195,116,710 |
195,174,436 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
ISO |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
increases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
decreases expression |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Glud1 |
glutamate dehydrogenase 1 |
|
multiple interactions |
ISO |
16 |
9,965,718 |
9,999,254 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
affects expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gper |
G protein-coupled estrogen receptor 1 |
|
multiple interactions |
EXP |
12 |
15,718,615 |
15,719,893 |
RGD:6480464 |
CTD |
| G |
Grin1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
|
decreases expression |
EXP |
3 |
3,453,784 |
3,480,381 |
RGD:6480464 |
CTD |
| G |
Grin2a |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
|
decreases expression |
EXP |
10 |
5,588,229 |
6,004,780 |
RGD:6480464 |
CTD |
| G |
Grin2b |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
|
decreases expression |
EXP |
4 |
172,721,895 |
173,183,187 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gtf2h1 |
general transcription factor IIH, polypeptide 1 |
|
decreases expression |
ISO |
1 |
97,352,251 |
97,380,298 |
RGD:6480464 |
CTD |
| G |
Heph |
hephaestin |
|
increases expression |
ISO |
X |
84,033,540 |
84,138,728 |
RGD:6480464 |
CTD |
| G |
Hfe |
hemochromatosis |
|
affects abundance |
ISO |
17 |
48,469,927 |
48,478,502 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
increases expression |
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1an |
hypoxia-inducible factor 1, alpha subunit inhibitor |
|
decreases expression |
ISO |
1 |
249,607,945 |
249,618,000 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
increases activity |
EXP |
2 |
27,127,504 |
27,149,580 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hoxb9 |
homeo box B9 |
|
decreases expression |
ISO |
10 |
85,002,254 |
85,005,760 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
increases expression |
ISO |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock 70kDa protein 8 |
|
multiple interactions |
ISO |
8 |
43,784,035 |
43,787,760 |
RGD:6480464 |
CTD |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
multiple interactions |
EXP |
2 |
36,434,518 |
36,435,786 |
RGD:6480464 |
CTD |
| G |
Htt |
huntingtin |
|
decreases uptake |
ISO |
14 |
81,490,322 |
81,636,856 |
RGD:6480464 |
CTD |
| G |
Htt |
huntingtin |
|
decreases abundance |
ISO |
14 |
81,490,322 |
81,636,856 |
RGD:6480464 |
CTD |
| G |
Htt |
huntingtin |
|
decreases response to substance |
ISO |
14 |
81,490,322 |
81,636,856 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
increases expression |
ISO |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Idh3a |
isocitrate dehydrogenase 3 (NAD+) alpha |
|
affects binding |
ISO |
8 |
58,135,412 |
58,156,019 |
RGD:6480464 |
CTD |
| G |
Idh3g |
isocitrate dehydrogenase 3 (NAD), gamma |
|
affects binding |
ISO |
X |
159,701,345 |
159,710,254 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
increases expression |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
2 |
123,655,005 |
123,659,709 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases secretion |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il7 |
interleukin 7 |
|
increases expression |
ISO |
2 |
96,356,083 |
96,399,796 |
RGD:6480464 |
CTD |
| G |
Ins1 |
insulin 1 |
|
multiple interactions |
EXP |
1 |
258,001,134 |
258,001,688 |
RGD:6480464 |
CTD |
| G |
Insr |
insulin receptor |
|
multiple interactions |
EXP |
12 |
2,934,967 |
3,087,691 |
RGD:6480464 |
CTD |
| G |
Ipo11 |
importin 11 |
|
decreases expression |
ISO |
2 |
38,006,409 |
38,054,430 |
RGD:6480464 |
CTD |
| G |
Ireb2 |
iron responsive element binding protein 2 |
|
decreases activity |
EXP |
8 |
58,433,218 |
58,477,305 |
RGD:6480464 |
CTD |
| G |
Ireb2 |
iron responsive element binding protein 2 |
|
increases expression |
EXP |
8 |
58,433,218 |
58,477,305 |
RGD:6480464 |
CTD |
| G |
Irs4 |
insulin receptor substrate 4 |
|
multiple interactions |
EXP |
X |
36,881,414 |
36,885,105 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
increases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itgam |
integrin, alpha M |
|
increases expression |
EXP |
1 |
187,334,413 |
187,385,583 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases activity |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
increases activity |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb5 |
integrin, beta 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
|
multiple interactions |
ISO |
16 |
6,364,102 |
6,378,251 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnj11 |
potassium inwardly rectifying channel, subfamily J, member 11 |
|
multiple interactions |
ISO |
1 |
96,614,960 |
96,617,993 |
RGD:6480464 |
CTD |
| G |
Kcnj3 |
potassium inwardly-rectifying channel, subfamily J, member 3 |
|
increases expression |
ISO |
3 |
37,068,672 |
37,256,990 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
decreases expression |
ISO |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Lefty2 |
Left-right determination factor 2 |
|
decreases expression |
ISO |
13 |
96,621,422 |
96,626,509 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases abundance |
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:6480464 |
CTD |
| G |
Lman2 |
lectin, mannose-binding 2 |
|
increases expression |
ISO |
17 |
15,313,291 |
15,331,470 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
multiple interactions |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map2k4 |
mitogen activated protein kinase kinase 4 |
|
decreases phosphorylation |
ISO |
10 |
52,009,149 |
52,041,599 |
RGD:6480464 |
CTD |
| G |
Map3k14 |
mitogen-activated protein kinase kinase kinase 14 |
|
multiple interactions |
EXP |
10 |
92,406,098 |
92,456,276 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
decreases phosphorylation |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
increases phosphorylation |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
increases phosphorylation |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
10 |
35,353,486 |
35,384,319 |
RGD:6480464 |
CTD |
| G |
Mbp |
myelin basic protein |
|
increases expression |
ISO |
18 |
78,943,608 |
79,057,329 |
RGD:6480464 |
CTD |
| G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
increases expression |
ISO |
7 |
119,557,141 |
119,559,619 |
RGD:6480464 |
CTD |
| G |
Mcm4 |
minichromosome maintenance complex component 4 |
|
decreases expression |
ISO |
11 |
87,169,742 |
87,183,443 |
RGD:6480464 |
CTD |
| G |
Mcm5 |
minichromosome maintenance complex component 5 |
|
decreases expression |
ISO |
19 |
13,978,940 |
14,000,641 |
RGD:6480464 |
CTD |
| G |
Me3 |
malic enzyme 3, NADP(+)-dependent, mitochondrial |
|
increases expression |
ISO |
1 |
146,220,504 |
146,422,659 |
RGD:6480464 |
CTD |
| G |
Mia |
melanoma inhibitory activity |
|
increases expression |
ISO |
1 |
82,255,458 |
82,257,125 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
decreases expression |
ISO |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mmp2 |
matrix metallopeptidase 2 |
|
decreases expression |
ISO |
19 |
15,246,036 |
15,275,061 |
RGD:6480464 |
CTD |
| G |
Msh6 |
mutS homolog 6 (E. coli) |
|
decreases expression |
ISO |
6 |
11,525,292 |
11,542,592 |
RGD:6480464 |
CTD |
| G |
Mtm1 |
myotubularin 1 |
|
decreases expression |
ISO |
7 |
247,960 |
265,281 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
increases phosphorylation |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Myom1 |
myomesin 1 |
|
increases expression |
ISO |
9 |
110,218,668 |
110,341,029 |
RGD:6480464 |
CTD |
| G |
Myt1l |
myelin transcription factor 1-like |
|
increases expression |
ISO |
6 |
47,435,167 |
47,828,030 |
RGD:6480464 |
CTD |
| G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
increases expression |
ISO |
6 |
51,129,160 |
51,166,514 |
RGD:6480464 |
CTD |
| G |
Ndrg1 |
N-myc downstream regulated 1 |
|
increases expression |
ISO |
7 |
104,302,038 |
104,344,842 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
multiple interactions |
EXP |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
increases expression |
ISO |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
decreases expression |
ISO |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfyb |
nuclear transcription factor-Y beta |
|
decreases expression |
ISO |
7 |
23,190,295 |
23,205,611 |
RGD:6480464 |
CTD |
| G |
Nmt1 |
N-myristoyltransferase 1 |
|
multiple interactions |
ISO |
10 |
92,196,640 |
92,230,571 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
decreases expression |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases activity |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
multiple interactions |
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Notch4 |
notch 4 |
|
decreases expression |
ISO |
20 |
4,263,205 |
4,287,312 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
decreases expression |
ISO |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases activity |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nrg2 |
neuregulin 2 |
|
increases expression |
ISO |
18 |
28,650,097 |
28,828,772 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
increases expression |
ISO |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
decreases expression |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
|
decreases expression |
ISO |
6 |
142,904,062 |
142,905,783 |
RGD:6480464 |
CTD |
| G |
Nudt9 |
nudix (nucleoside diphosphate linked moiety X)-type motif 9 |
|
multiple interactions |
ISO |
14 |
6,809,091 |
6,840,664 |
RGD:6480464 |
CTD |
| G |
Nudt9 |
nudix (nucleoside diphosphate linked moiety X)-type motif 9 |
|
increases activity |
ISO |
14 |
6,809,091 |
6,840,664 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
decreases expression |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Olfm1 |
olfactomedin 1 |
|
increases expression |
ISO |
3 |
7,170,421 |
7,195,345 |
RGD:6480464 |
CTD |
| G |
Oprd1 |
opioid receptor, delta 1 |
|
multiple interactions |
EXP |
5 |
150,979,252 |
151,014,066 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
multiple interactions |
EXP |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Oprm1 |
opioid receptor, mu 1 |
|
multiple interactions |
EXP |
1 |
37,535,416 |
37,779,392 |
RGD:6480464 |
CTD |
| G |
Pappa |
pregnancy-associated plasma protein A |
|
increases expression |
ISO |
5 |
81,826,649 |
82,096,446 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
decreases expression |
EXP |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
decreases transport |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
affects response to substance |
ISO |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park2 |
parkinson protein 2, E3 ubiquitin protein ligase |
|
increases expression |
EXP |
1 |
43,151,265 |
44,374,470 |
RGD:6480464 |
CTD |
| G |
Park7 |
parkinson protein 7 |
|
decreases expression |
EXP |
5 |
168,050,149 |
168,061,616 |
RGD:6480464 |
CTD |
| G |
Pcdh7 |
protocadherin 7 |
|
increases expression |
ISO |
14 |
56,609,036 |
57,323,892 |
RGD:6480464 |
CTD |
| G |
Pcdha6 |
protocadherin alpha 6 |
|
increases expression |
ISO |
18 |
29,697,876 |
29,928,030 |
RGD:6480464 |
CTD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
increases expression |
ISO |
3 |
54,292,076 |
54,319,242 |
RGD:6480464 |
CTD |
| G |
Pgf |
placental growth factor |
|
increases expression |
ISO |
6 |
109,215,540 |
109,226,122 |
RGD:6480464 |
CTD |
| G |
Phtf1 |
putative homeodomain transcription factor 1 |
|
decreases expression |
ISO |
2 |
199,202,647 |
199,241,476 |
RGD:6480464 |
CTD |
| G |
Plce1 |
phospholipase C, epsilon 1 |
|
increases expression |
ISO |
1 |
242,794,858 |
243,103,437 |
RGD:6480464 |
CTD |
| G |
Pln |
phospholamban |
|
decreases expression |
ISO |
20 |
32,000,371 |
32,008,559 |
RGD:6480464 |
CTD |
| G |
Pou1f1 |
POU class 1 homeobox 1 |
|
increases expression |
ISO |
11 |
2,959,383 |
2,980,545 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppp1r1b |
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
|
increases phosphorylation |
EXP |
10 |
87,121,889 |
87,131,587 |
RGD:6480464 |
CTD |
| G |
Prim2 |
primase, DNA, polypeptide 2 |
|
decreases expression |
ISO |
9 |
32,206,274 |
32,424,970 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
increases phosphorylation |
EXP |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
increases phosphorylation |
EXP |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Prkd1 |
protein kinase D1 |
|
increases expression |
ISO |
6 |
70,364,135 |
70,682,006 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
increases stability |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
multiple interactions |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Prnp |
prion protein |
|
affects binding |
ISO |
3 |
119,676,137 |
119,691,507 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
increases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
EXP |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
decreases expression |
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:6480464 |
CTD |
| G |
Ptx3 |
pentraxin 3, long |
|
increases expression |
ISO |
2 |
156,089,917 |
156,095,726 |
RGD:6480464 |
CTD |
| G |
PVR |
poliovirus receptor |
|
decreases expression |
ISO |
1 |
79,213,654 |
79,229,063 |
RGD:6480464 |
CTD |
| G |
Rab21 |
RAB21, member RAS oncogene family |
|
decreases expression |
ISO |
7 |
54,550,247 |
54,575,032 |
RGD:6480464 |
CTD |
| G |
Rab23 |
RAB23, member RAS oncogene family |
|
decreases expression |
ISO |
9 |
32,465,752 |
32,486,615 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
affects localization |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rfc5 |
replication factor C (activator 1) 5 |
|
decreases expression |
ISO |
12 |
40,395,942 |
40,405,498 |
RGD:6480464 |
CTD |
| G |
Rgs2 |
regulator of G-protein signaling 2 |
|
increases expression |
ISO |
13 |
57,891,849 |
57,894,452 |
RGD:6480464 |
CTD |
| G |
Rgs5 |
regulator of G-protein signaling 5 |
|
decreases expression |
ISO |
13 |
85,445,325 |
85,482,294 |
RGD:6480464 |
CTD |
| G |
Rgs6 |
regulator of G-protein signaling 6 |
|
increases expression |
ISO |
6 |
106,470,420 |
106,964,581 |
RGD:6480464 |
CTD |
| G |
Rnf145 |
ring finger protein 145 |
|
increases expression |
ISO |
10 |
29,680,833 |
29,720,064 |
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
decreases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
increases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
decreases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rpe65 |
retinal pigment epithelium 65 |
|
increases uptake |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
increases expression |
ISO |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
Scn3b |
sodium channel, voltage-gated, type III, beta |
|
increases expression |
ISO |
8 |
43,231,453 |
43,254,066 |
RGD:6480464 |
CTD |
| G |
Sdcbp2 |
syndecan binding protein (syntenin) 2 |
|
decreases expression |
ISO |
3 |
141,891,232 |
141,919,905 |
RGD:6480464 |
CTD |
| G |
Sftpb |
surfactant protein B |
|
increases expression |
ISO |
4 |
105,609,410 |
105,618,452 |
RGD:6480464 |
CTD |
| G |
Sfxn5 |
sideroflexin 5 |
|
increases expression |
ISO |
4 |
119,462,697 |
119,583,363 |
RGD:6480464 |
CTD |
| G |
Sirt2 |
sirtuin 2 |
|
increases expression |
ISO |
1 |
83,873,578 |
83,896,121 |
RGD:6480464 |
CTD |
| G |
Six3 |
SIX homeobox 3 |
|
increases expression |
ISO |
6 |
8,981,995 |
9,019,365 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases uptake |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
decreases metabolic processing |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
EXP |
7 |
139,094,505 |
139,127,427 |
RGD:6480464 |
CTD |
| G |
Slc16a3 |
solute carrier family 16, member 3 (monocarboxylic acid transporter 4) |
|
increases expression |
ISO |
10 |
110,159,679 |
110,163,182 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
EXP |
1 |
265,789,917 |
265,824,551 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
decreases expression |
EXP |
3 |
87,870,558 |
87,992,401 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
multiple interactions |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a3 |
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
|
decreases expression |
EXP |
2 |
58,270,236 |
58,347,613 |
RGD:6480464 |
CTD |
| G |
Slc1a5 |
solute carrier family 1 (neutral amino acid transporter), member 5 |
|
multiple interactions |
EXP |
1 |
77,111,082 |
77,125,166 |
RGD:6480464 |
CTD |
| G |
Slc22a15 |
solute carrier family 22, member 15 |
|
decreases expression |
ISO |
2 |
196,953,291 |
197,013,763 |
RGD:6480464 |
CTD |
| G |
Slc2a13 |
solute carrier family 2 (facilitated glucose transporter), member 13 |
|
increases expression |
ISO |
7 |
129,682,782 |
130,005,752 |
RGD:6480464 |
CTD |
| G |
Slc38a1 |
solute carrier family 38, member 1 |
|
decreases expression |
EXP |
7 |
135,252,257 |
135,316,256 |
RGD:6480464 |
CTD |
| G |
Slc38a10 |
solute carrier family 38, member 10 |
|
increases expression |
ISO |
10 |
109,516,004 |
109,569,804 |
RGD:6480464 |
CTD |
| G |
Slc38a3 |
solute carrier family 38, member 3 |
|
multiple interactions |
EXP |
8 |
112,898,405 |
112,914,444 |
RGD:6480464 |
CTD |
| G |
Slc38a3 |
solute carrier family 38, member 3 |
|
decreases expression |
EXP |
8 |
112,898,405 |
112,914,444 |
RGD:6480464 |
CTD |
| G |
Slc39a14 |
solute carrier family 39 (zinc transporter), member 14 |
|
increases expression |
ISO |
15 |
50,703,198 |
50,749,644 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
multiple interactions |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
increases uptake |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc4a10 |
solute carrier family 4, sodium bicarbonate transporter, member 10 |
|
decreases expression |
ISO |
3 |
43,979,103 |
44,274,283 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
decreases expression |
EXP |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases response to substance |
ISO |
1 |
30,516,568 |
30,557,540 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
increases expression |
EXP |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Smim14 |
small integral membrane protein 14 |
|
increases expression |
ISO |
14 |
45,477,213 |
45,520,785 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
increases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
increases uptake |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
increases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sort1 |
sortilin 1 |
|
decreases expression |
ISO |
2 |
203,853,009 |
203,931,559 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
multiple interactions |
EXP |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spa17 |
sperm autoantigenic protein 17 |
|
decreases expression |
ISO |
8 |
38,843,007 |
38,852,080 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Stox1 |
storkhead box 1 |
|
decreases expression |
ISO |
20 |
29,904,966 |
29,977,218 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Sult1c3 |
sulfotransferase family, cytosolic, 1C, member 3 |
|
increases expression |
ISO |
9 |
486,576 |
531,962 |
RGD:6480464 |
CTD |
| G |
Syn1 |
synapsin I |
|
increases phosphorylation |
EXP |
X |
12,512,241 |
12,556,160 |
RGD:6480464 |
CTD |
| G |
Tab1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
|
affects binding |
ISO |
7 |
118,368,997 |
118,402,928 |
RGD:6480464 |
CTD |
| G |
Tacr1 |
tachykinin receptor 1 |
|
decreases expression |
ISO |
4 |
116,610,595 |
116,780,394 |
RGD:6480464 |
CTD |
| G |
Tagln2 |
transgelin 2 |
|
decreases expression |
ISO |
13 |
88,505,258 |
88,512,178 |
RGD:6480464 |
CTD |
| G |
Tbx18 |
T-box18 |
|
increases expression |
ISO |
8 |
92,984,336 |
93,012,343 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
increases uptake |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
affects binding |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
multiple interactions |
EXP |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
affects binding |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tf |
transferrin |
|
multiple interactions |
ISO |
8 |
108,217,774 |
108,244,487 |
RGD:6480464 |
CTD |
| G |
Tfap2b |
transcription factor AP-2 beta |
|
increases expression |
ISO |
9 |
18,052,402 |
18,082,202 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
increases expression |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
increases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnrc6a |
trinucleotide repeat containing 6a |
|
increases expression |
ISO |
1 |
181,982,994 |
182,053,510 |
RGD:6480464 |
CTD |
| G |
Tpcn1 |
two pore segment channel 1 |
|
increases expression |
ISO |
12 |
37,140,428 |
37,227,711 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases transport |
ISO |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
multiple interactions |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpc6 |
transient receptor potential cation channel, subfamily C, member 6 |
|
increases uptake |
EXP |
8 |
5,472,515 |
5,577,537 |
RGD:6480464 |
CTD |
| G |
Trpm1 |
transient receptor potential cation channel, subfamily M, member 1 |
|
increases expression |
ISO |
1 |
118,583,516 |
118,700,653 |
RGD:6480464 |
CTD |
| G |
Trpm4 |
transient receptor potential cation channel, subfamily M, member 4 |
|
increases expression |
ISO |
1 |
95,773,485 |
95,803,542 |
RGD:6480464 |
CTD |
| G |
Trpm7 |
transient receptor potential cation channel, subfamily M, member 7 |
|
increases uptake |
EXP |
3 |
114,320,799 |
114,410,498 |
RGD:6480464 |
CTD |
| G |
Trpv3 |
transient receptor potential cation channel, subfamily V, member 3 |
|
decreases expression |
ISO |
10 |
60,126,243 |
60,171,718 |
RGD:6480464 |
CTD |
| G |
Tsga10 |
testis specific 10 |
|
increases expression |
ISO |
9 |
36,713,297 |
36,811,661 |
RGD:6480464 |
CTD |
| G |
Tyrp1 |
tyrosinase-related protein 1 |
|
decreases expression |
ISO |
5 |
99,518,306 |
99,537,289 |
RGD:6480464 |
CTD |
| G |
Uchl1 |
ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase) |
|
decreases expression |
EXP |
14 |
44,114,392 |
44,124,947 |
RGD:6480464 |
CTD |
| G |
Ucn |
urocortin |
|
multiple interactions |
EXP |
6 |
25,216,788 |
25,217,618 |
RGD:6480464 |
CTD |
| G |
Usp15 |
ubiquitin specific peptidase 15 |
|
decreases expression |
ISO |
7 |
62,871,167 |
62,961,405 |
RGD:6480464 |
CTD |
| G |
Usp45 |
ubiquitin specific peptidase 45 |
|
decreases expression |
ISO |
5 |
36,517,213 |
36,590,986 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
increases expression |
ISO |
10 |
37,795,721 |
37,823,253 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vps13a |
vacuolar protein sorting 13 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
1 |
219,987,826 |
220,221,494 |
RGD:6480464 |
CTD |
| G |
Wt1 |
Wilms tumor 1 |
|
decreases expression |
ISO |
3 |
90,529,704 |
90,577,280 |
RGD:6480464 |
CTD |
| G |
Zfp41 |
zinc finger protein 41 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
Term paths to the root
|